Patheon Inc.

We believe the world would be a healthier place if tomorrow's medicines were made available today. Patheon is transforming the way pharmaceuticals are made with a simplified, end-to-end supply chain solution for pharmaceutical and biopharmaceutical companies of all sizes. Drug substances and drug products. Development and manufacturing. Small and large molecules. Sterile, oral solid and softgel dosage forms. Patheon offers a comprehensive range of services spanning all phases and scales that is wider and deeper than that of any other CDMO.

Patheon gives even the smallest pharma and biotech companies instant access to a fully integrated global network of facilities across North America, Europe, Asia and Australia. This includes eleven for commercial-scale finished dosage forms, four for API process development and manufacturing, four for biologics, and ten for pharmaceutical development.

Our global leadership is built upon a reputation for scientific and technical excellence. This includes specialized capabilities for highly potent and controlled substances, aseptic filling and lyophilization, complex formulations, solubility enhancement and difficult to manufacture APIs. There is also Patheon OneSource™ a program that aligns development of drug substance and drug product in a coordinated drive toward proof of concept that can take months off of development timelines.

Patheon has more than 8,400 scientific and professional staff and over 40 years of experience. We deliver unrivaled quality, reliability and compliance. Together with more than 400 clients, Patheon is rapidly turning pharmaceutical possibilities into reality.